Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 10 studies | 25% ± 11% | |
| astrocyte | 5 studies | 26% ± 7% | |
| non-classical monocyte | 4 studies | 19% ± 7% | |
| monocyte | 4 studies | 26% ± 7% | |
| myeloid cell | 3 studies | 27% ± 10% | |
| GABAergic neuron | 3 studies | 49% ± 6% | |
| glutamatergic neuron | 3 studies | 63% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
| macrophage | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 40% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2533.99 | 2642 / 2642 | 100% | 21.90 | 705 / 705 |
| prostate | 96% | 548.87 | 234 / 245 | 100% | 4.26 | 500 / 502 |
| thymus | 99% | 713.67 | 647 / 653 | 96% | 3.01 | 578 / 605 |
| liver | 100% | 863.11 | 226 / 226 | 94% | 5.71 | 381 / 406 |
| ovary | 98% | 629.48 | 177 / 180 | 94% | 2.77 | 403 / 430 |
| adrenal gland | 98% | 708.32 | 253 / 258 | 93% | 4.90 | 215 / 230 |
| kidney | 98% | 579.47 | 87 / 89 | 94% | 4.41 | 845 / 901 |
| breast | 99% | 1016.11 | 453 / 459 | 92% | 3.88 | 1030 / 1118 |
| lung | 100% | 1633.43 | 576 / 578 | 88% | 3.56 | 1013 / 1155 |
| bladder | 95% | 642.71 | 20 / 21 | 66% | 2.05 | 334 / 504 |
| stomach | 86% | 488.94 | 307 / 359 | 74% | 2.23 | 213 / 286 |
| uterus | 98% | 776.92 | 167 / 170 | 58% | 2.21 | 267 / 459 |
| intestine | 88% | 724.33 | 848 / 966 | 68% | 1.82 | 357 / 527 |
| pancreas | 68% | 258.27 | 222 / 328 | 84% | 2.29 | 150 / 178 |
| skin | 48% | 197.30 | 860 / 1809 | 89% | 5.18 | 420 / 472 |
| esophagus | 69% | 497.06 | 999 / 1445 | 64% | 2.21 | 118 / 183 |
| muscle | 100% | 1485.91 | 803 / 803 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1504.95 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1059.31 | 240 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 874.55 | 1313 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1803.77 | 901 / 929 | 0% | 0 | 0 / 0 |
| heart | 83% | 430.87 | 716 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 2.84 | 22 / 29 |
| eye | 0% | 0 | 0 / 0 | 63% | 1.65 | 50 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 56% | 1.28 | 25 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TMEM170B |
| Protein name | Transmembrane protein 170B |
| Synonyms | |
| Description | FUNCTION: Negatively regulates the canonical Wnt signaling in breast cancer cells. Exerts an inhibitory effect on breast cancer growth by inhibiting CTNNB1 stabilization and nucleus translocation, which reduces the activity of Wnt targets . . |
| Accessions | Q5T4T1 ENST00000379426.2 |
